Definition and epidemiology
Barbiturate overdose refers to toxicity from excessive ingestion (intentional or accidental) of barbiturate drugs such as phenobarbital, pentobarbital, secobarbital, butalbital, or thiopental. These agents were once widely prescribed as sedative-hypnotics and anticonvulsants but have largely been replaced by benzodiazepines and newer antiepileptics due to their narrow therapeutic index and high lethality in overdose.
- Barbiturate overdose is now relatively uncommon compared to the mid-20th century, when it was a leading cause of drug-related death and suicide.
- Phenobarbital remains in use for neonatal seizures, status epilepticus, and alcohol/benzodiazepine withdrawal protocols, which keeps it clinically relevant.
- At-risk groups: patients with epilepsy on long-term phenobarbital, individuals with substance use disorder (F13 category), and patients attempting self-harm.
- Mortality is historically higher than benzodiazepine overdose because of a lower therapeutic index and lack of a specific reversal agent.
- Barbiturates increase the DURATION of GABA-A chloride channel opening; benzodiazepines increase the FREQUENCY.
- Classic triad: CNS depression, respiratory depression, hypotension.
- Pupils are usually normal or variable in barbiturate overdose, not miotic; fixed/dilated pupils signal severe hypoxic injury.
- No specific antidote exists; management is supportive.
- Multidose activated charcoal and urine alkalinization are used for phenobarbital due to enterohepatic recirculation and renal ion trapping.
- Hemodialysis is effective for severe phenobarbital toxicity but not for short-acting barbiturates.
- Severe coma can mimic brain death — confirm drug clearance before any brain-death determination.
- Flumazenil and naloxone are not effective for isolated barbiturate overdose.
Etiology and risk factors
- Intentional overdose (suicide attempt) is the most common cause in adults presenting to the emergency department.
- Chronic therapeutic use with accumulation, especially in renal/hepatic impairment (phenobarbital is partly renally excreted).
- Co-ingestion with alcohol, opioids, or benzodiazepines, which synergistically potentiates CNS and respiratory depression.
- Iatrogenic overdose during induction of anesthesia (thiopental) or aggressive seizure management.
- Withdrawal from chronic barbiturate use is itself dangerous (seizures, autonomic instability) and is a related but distinct risk-factor consideration.
- Tolerance and physical dependence develop with chronic use, categorized under F13 (sedative, hypnotic, or anxiolytic-related disorders).
Pathophysiology
Barbiturates bind the GABA-A receptor at a site distinct from benzodiazepines and increase the duration of chloride channel opening (versus benzodiazepines, which increase the frequency of opening). At higher concentrations, barbiturates can directly activate the GABA-A channel independent of GABA itself, which explains their greater capacity to cause profound, potentially fatal CNS depression even without co-ingestants.
- Enhanced chloride influx causes neuronal hyperpolarization, suppressing cortical and brainstem activity.
- Direct myocardial depression and vasodilation at high doses cause hypotension and shock.
- Loss of hypothalamic thermoregulation produces hypothermia.
- Medullary respiratory center depression causes bradypnea, apnea, and hypoxia, which is usually the proximate cause of death.
- Barbiturates also reduce cerebral metabolic rate and intracranial pressure, a property exploited therapeutically (e.g., pentobarbital coma for refractory elevated ICP) but which parallels the mechanism of toxicity.
Clinical features
Presentation ranges from mild sedation to deep coma depending on dose and tolerance.
Classic triad
- CNS depression (lethargy progressing to coma)
- Respiratory depression (shallow, slow breathing, apnea)
- Hypotension
Additional findings
- Hypothermia
- Hyporeflexia or absent deep tendon reflexes
- Nystagmus, slurred speech, ataxia (at lower doses)
- Pupils are usually normal or variable in size (unlike the miosis of opioid overdose); they may become fixed and dilated with severe hypoxic brain injury, mimicking brain death
- Characteristic skin findings: bullous lesions ("barb burns" or "barbiturate blisters"), typically over pressure points
- Decreased bowel sounds (ileus)
Severe cases can mimic brainstem death with absent reflexes and flat EEG, which is an important and testable pitfall — clinical determination of death must be delayed until the drug is cleared.
Diagnosis
Diagnosis is largely clinical, supported by history and toxicology.
- History: known prescription, empty pill bottles, suicide note, chronic epilepsy treatment.
- Serum barbiturate level: confirms exposure; phenobarbital levels correlate reasonably well with severity and guide decisions about enhanced elimination.
- Urine toxicology screen: qualitative confirmation; does not reflect severity.
- ABG: respiratory acidosis from hypoventilation.
- Electrolytes, renal function, glucose: baseline and to rule out contributing causes of altered mental status.
- ECG: assess for co-ingestant cardiotoxicity.
- CT head: to exclude structural causes of coma if diagnosis uncertain.
- EEG: may show burst suppression in deep coma; important when distinguishing from brain death.
A practical table of severity:
| Severity | Features |
|---|---|
| Mild | Drowsiness, ataxia, slurred speech |
| Moderate | Stupor, depressed reflexes, hypotension |
| Severe | Coma, apnea, shock, hypothermia |
Differential diagnosis
- Benzodiazepine overdose (less respiratory depression, flumazenil-responsive)
- Opioid overdose (miosis, naloxone-responsive, less hypotension typically)
- Alcohol intoxication/toxic alcohol ingestion
- Tricyclic antidepressant overdose (cardiotoxicity, wide QRS)
- Carbon monoxide poisoning
- Hypoglycemia
- Stroke or other structural brain lesion
- Brain death (must be excluded before withdrawal of care in deep barbiturate coma)
Management
There is no specific antidote for barbiturate overdose; management is primarily supportive, following international toxicology guidance (WHO poisoning management principles, American College of Medical Toxicology).
Immediate supportive care
- Airway, breathing, circulation: intubation and mechanical ventilation for airway protection or respiratory failure.
- IV fluids and vasopressors for hypotension refractory to fluids.
- Rewarming for hypothermia.
- Continuous cardiac and neurologic monitoring.
Decontamination and elimination
- Activated charcoal, single or multidose, if the patient presents early and airway is protected; multidose charcoal is particularly useful for phenobarbital because it undergoes enterohepatic recirculation.
- Urine alkalinization (sodium bicarbonate) enhances elimination of long-acting barbiturates like phenobarbital by ion trapping; it is not effective for short-acting agents.
- Hemodialysis or hemoperfusion for severe phenobarbital toxicity, renal failure, hemodynamic instability, or very high serum levels, since phenobarbital is dialyzable.
- Gastric lavage is rarely used and reserved for life-threatening ingestions presenting very early.
Key exam point
Flumazenil and naloxone have no role in isolated barbiturate overdose (they target benzodiazepine and opioid receptors respectively), though they may be used empirically if co-ingestion is suspected.
Complications and prognosis
- Aspiration pneumonia from decreased airway protective reflexes.
- Acute respiratory failure requiring prolonged ventilatory support.
- Rhabdomyolysis and pressure-related skin bullae/necrosis from prolonged immobility.
- Acute kidney injury (from rhabdomyolysis or shock).
- Hypoxic-ischemic brain injury if respiratory depression is prolonged before intervention.
- Withdrawal syndrome (tremor, anxiety, seizures, autonomic instability) if chronic use is interrupted abruptly during recovery, requiring a gradual taper.
Prognosis is generally good with early aggressive supportive care; most deaths result from untreated respiratory depression and aspiration rather than direct cardiotoxicity. Historically, barbiturate overdose carried higher mortality than benzodiazepine overdose because of the narrower therapeutic index.
"DUR" vs "FREQ": Barbiturates = DURation of GABA-A channel opening up; Benzodiazepines = FREQuency of opening up.
Practice questions
1. A 34-year-old woman with a history of depression is found unresponsive next to an empty bottle of phenobarbital tablets. On exam, she has shallow respirations at 6/min, blood pressure 78/48 mmHg, temperature 34.8°C, and absent deep tendon reflexes. Which of the following best explains the mechanism of her presentation?
2. A patient with chronic phenobarbital use for epilepsy presents with lethargy and a serum phenobarbital level significantly above the therapeutic range. Renal function is normal. Which intervention is most appropriate to enhance elimination of the drug?
3. A 45-year-old man is brought to the ICU after a large barbiturate ingestion. He is deeply comatose with absent brainstem reflexes and a flat EEG. The family asks whether he meets criteria for brain death. What is the most appropriate next step?
Frequently asked questions
What causes barbiturate overdose?
Barbiturate overdose is caused by ingesting an excessive dose of a barbiturate drug, most often phenobarbital, either intentionally in a suicide attempt or accidentally through chronic therapeutic use, drug interactions, or co-ingestion with alcohol or other sedatives. Renal or hepatic impairment can also cause drug accumulation to toxic levels even at prescribed doses.
What are the first symptoms of barbiturate overdose?
Early symptoms include drowsiness, slurred speech, ataxia, and nystagmus, resembling alcohol intoxication. As the dose or blood level rises, this progresses to stupor, respiratory depression, hypotension, hypothermia, and eventually coma, which is the hallmark of severe toxicity.
How is barbiturate overdose diagnosed?
Diagnosis is based on history of ingestion plus clinical findings of CNS and respiratory depression, confirmed by serum barbiturate levels and urine toxicology screening. Arterial blood gas, electrolytes, and ECG are obtained to assess severity and exclude co-ingestants, and CT head may be used if the cause of coma is unclear.
Is barbiturate overdose curable?
Yes, most patients recover fully with prompt supportive care such as airway protection, ventilation, and enhanced elimination for phenobarbital. There is no specific antidote, so outcome depends on how quickly respiratory depression and hypotension are recognized and treated; delayed care raises the risk of hypoxic brain injury or death.
Barbiturate overdose vs benzodiazepine overdose — what is the difference?
Barbiturates increase the duration of GABA-A channel opening and can directly activate the channel at high doses, causing deeper respiratory depression, hypotension, and a narrower therapeutic index than benzodiazepines, which only increase channel opening frequency. Benzodiazepine overdose is generally safer and reversible with flumazenil, while no such reliable antidote exists for barbiturates.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F13
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.